Bronchodilator effect of theophylline preparations and aerosol fenoterol in stable asthma.
To compare the acute bronchodilator effect of increasing doses of intravenous theophylline and inhaled beta adrenergic agonists, we administered intravenous theophylline dissolved in ethylenediamine or proxyphylline and diprophylline or placebo in a double blind fashion to nine asthmatics on three different days. At each session, 100 mg theophylline or placebo were given during each of five subsequent periods of 30 minutes' duration and followed by inhalation of 0.4 mg fenoterol. In contrast to placebo, 500 mg theophylline in ethylenediamine or proxyphylline and diprophylline significantly decreased mean specific airway resistance (SRaw in cmH2O.s) from 31.2 to 23.6 or 34.2 to 23.5 at theophylline serum concentrations of 14.4 or 16.6 mg/L, respectively. Fenoterol lowered SRaw to about 40 percent of the respective baseline values independent of theophylline or placebo pretreatment. We conclude that the acute bronchodilator effect of theophylline is weak in comparison to inhaled beta agonists. Furthermore, proxyphylline and diprophylline cause a weak but not significant bronchodilation when compared to ethylenediamine.
D000403:Airway Resistance / Q000187:drug effects; D000628:Aminophylline / Q000008:administration & dosage / Q000031:analogs & derivatives; D001249:Asthma / Q000097:blood / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004357:Drug Synergism; D004400:Dyphylline / Q000008:administration & dosage; D005280:Fenoterol / Q000627:therapeutic use*; D005541:Forced Expiratory Volume; D006801:Humans; D013806:Theophylline / Q000097:blood / Q000627:therapeutic use* / Q000031:analogs & derivatives
C003237:proxyphylline; D005280:Fenoterol; D004400:Dyphylline; D000628:Aminophylline; D013806:Theophylline